share_log

藥明生物:分拆WUXI XDC CAYMAN INC. 並於香港聯合交易所有限公司主板獨立上市的最新資料 - 超額配股權獲悉數行使

WUXI BIO: UPDATE ON THE SPIN-OFF AND SEPARATE LISTING OF WUXI XDC CAYMAN INC. ON THE MAIN BOARD OF THE STOCK EXCHANGE OF HONG KONG LIMITED - FULL EXERCISE OF THE OVER-ALLOTMENT OPTION

香港交易所 ·  Dec 10, 2023 05:15
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more